Fukoku Mutual Life Insurance CO Vertex Pharmaceuticals Inc Transaction History

Fukoku Mutual Life Insurance CO

$1.39 Billion
Q3 2024

A detailed history of Fukoku Mutual Life Insurance CO transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fukoku Mutual Life Insurance CO holds 1,855 shares of VRTX stock, worth $863,873. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,855

Previous 1,855 -0.0%

Holding current value

$863,873

Previous $869,000 0.81%

% of portfolio

0.06%

Previous 0.07%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$392.81 - $485.53 $65,206 - $80,597	-166 Reduced 8.21%	1,855 $869,000
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $48,515 - $53,083	-119 Reduced 5.56%	2,021 $844,000
Q4 2023 Feb 09, 2024	SELL	$343.0 - $410.68 $171,500 - $205,340	-500 Reduced 18.94%	2,140 $870,000
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $169,090 - $181,230	500 Added 23.36%	2,640 $918,000
Q1 2023 Apr 18, 2023	SELL	$283.23 - $323.1 $283,230 - $323,100	-1,000 Reduced 31.85%	2,140 $674,000
Q4 2022 Jan 31, 2023	BUY	$285.76 - $321.48 $491,507 - $552,945	1,720 Added 121.13%	3,140 $906,000
Q2 2022 Jul 29, 2022	SELL	$234.96 - $292.55 $7,048 - $8,776	-30 Reduced 2.07%	1,420 $400,000
Q1 2022 May 10, 2022	SELL	$221.42 - $260.97 $22,142 - $26,097	-100 Reduced 6.45%	1,450 $378,000
Q4 2021 Jan 25, 2022	BUY	$177.01 - $223.45 $10,620 - $13,407	60 Added 4.03%	1,550 $340,000
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $38,091 - $42,627	-210 Reduced 12.35%	1,490 $270,000
Q3 2020 Nov 03, 2020	BUY	$255.65 - $303.1 $51,130 - $60,620	200 Added 13.33%	1,700 $463,000
Q4 2019 Jan 31, 2020	BUY	$166.71 - $223.91 $33,342 - $44,782	200 Added 15.38%	1,500 $328,000
Q1 2019 May 01, 2019	SELL	$163.73 - $194.7 $16,372 - $19,470	-100 Reduced 7.14%	1,300 $239,000
Q4 2018 Jan 30, 2019	BUY	$151.91 - $192.21 $30,382 - $38,442	200 Added 16.67%	1,400 $232,000
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $33,546 - $38,548	-200 Reduced 14.29%	1,200 $231,000
Q3 2017 Nov 14, 2017	SELL	$148.13 - $162.24 $14,813 - $16,224	-100 Reduced 6.67%	1,400 $213,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,500	1,500 $193,000

Others Institutions Holding VRTX

# of Institutions

1,722

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fukoku Mutual Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Fukoku Mutual Life Insurance CO with notifications on news.

Account

Fukoku Mutual Life Insurance CO Vertex Pharmaceuticals Inc Transaction History